Preview

Epidemiology and Vaccinal Prevention

Advanced search

Application of Imunofan, Polioksidoniy, Ronkoleykin, Salmozan and Fosprenil for Stimulating the Humoral Immune Response in Rabbits Immunized against Enteroviruses

https://doi.org/10.31631/2073-3046-2016-15-4-53-58

Abstract

Enterprise of viral and bacterial Preparations of Chumakov Institute of poliomyelitis and viral encephalitides, Moscow Abstract Selective and inconstant adjuvant activities of the agents Imunofan, Polioksidoniy, Roncoleykin, Salmozan and Fosprenil were determined. Those agents were used as an additional stimulant of the immune response in rabbit immunized with enteroviruses to get the polyclonal diagnostic sera for neutralization.

About the Authors

V. G. Kozlov
ФГУП «Предприятие по производству бактерийных и вирусных препаратов Института полиомиелита и вирусных энцефалитов им. М.П. Чумакова»
Russian Federation


Yu. Kh. Khapchaev
ФГУП «Предприятие по производству бактерийных и вирусных препаратов Института полиомиелита и вирусных энцефалитов им. М.П. Чумакова»
Russian Federation


A. A. Ishmukhametov
ФГУП «Предприятие по производству бактерийных и вирусных препаратов Института полиомиелита и вирусных энцефалитов им. М.П. Чумакова»
Russian Federation


References

1. Grandien M., Forsgren M., Ehrnst A. Enteroviruses. In: Diagnostic procedures for viral, rickettsial, and chlamydial infections. Eds.: Lennette E.H., Lennette D.A., Lennette E.T. Wachington, DC: American Public Health Assotiation. 1995: 279 – 297.

2. Kiang D., Newbower E.C, Yeh E., Wold L., Chen L., Schnurr D. An algoritm for the typing of enteroviruses and correlation to serotyping by viral neutralization. J. Clin. Virol. 2009; 45: 334 – 340.

3. Khetsuriani N., Parashar U.D. Enteric viral infections: the clinician’s guide to diagnosis, treatment and prevention. In: Scentific American Medicine. Eds.: Dale D.C., Federman D.D..N.-Y.; 2003: 1758 – 1766.

4. Palacios G., Oberste M.S. Enterovirus as agents of emerging infectious diseases. J. Neurol. 2005, 11: 424 – 433.

5. Morozova N.S., Chernyavskaya O.P., Yasinskyi A.A., Voronzova T.V. Epidemiological surveillance of enterovirus (non-polio) infection in the Russian Federation. Medicinskaya Virusologiya. [Medical Virology]. Chumakov Institute of Poliomyelitis and Viral Encephalitides. 2009; 26: 39 – 41 (in Russian).

6. Lebedeva L.A., Reznik V.I., Rebrova O.I. Savosina L.V., Prysyazhnyuk E.N., Amyaga E.N. Laboratory-based surveillance of enterovirus infection in Eastern Russia in the year 2014. Medicinskaya Virusologiya. [Medical Virology]. Chumakov Institute of Poliomyelitis and Viral Encephalitides. 2015; 29 (2): 105 – 106 (in Russian).

7. Novikova N.A., Golizina L.N., Zverev V.V., Еpifanova N.V., Kashnikov A.Y., Sashina T.A. et al. Molecular monitoring of non-polio enterovirus circulation in Russia (2008 – 2015). Medicinskaya Virusologiya. [Medical Virology]. Chumakov Institute of Poliomyelitis and Viral Encephalitides. 2015;. 29 (2): 110 (in Russian).

8. Kozlov V.G. Scientific methodological and experimental approach of production improvement of diagnostic enterovirus sera. Medicinskaya Virusologiya. [Medical Virology]. Chumakov Institute of Poliomyelitis and Viral Encephalitides. 2009; 26: 31 – 33 (in Russian).

9. Kozlov V.G. New generation of polyclonal enteroviral diagnostic sera. Epidemiologiya i infekcionnije bolezni. [Epidemiology and infectious diseases]. 2014; 3: 51 – 56 (in Russian).

10. Imunofan. www.rlsnet.ru (in Russian).

11. Polioxidonium. www.rlsnet.ru (in Russian).

12. Roncoleukinum. www.vetLek.ru (in Russian).

13. Salmosanum. www.webvet.ru (in Russian).

14. Fosprenil. www.fosprenil.ru (in Russian).

15. Polio Laboratory Manual, 2004, 4th edition Geneva: Department of Vaccines and Biologicals, World Health Organization; 2004.

16. National Foundation for Infantile Paralysis. Preparation and use of ECHO virus rabbit antisera for types 1 to 14 and Coxsackie virus antisera for types B1 to B5 and A9, prepared by Microbiological Associations Inc. 1957.

17. Odean M.J., Van Frane C.M., der Vieren M., Tomai. M.A., Johnson A.G. Involvement of gamma interferon in antibody enhancement by adjuvants. Infect. Immun. 1990; 58: 427 – 432.

18. Bliss J., Maylor R., Stokes K., Murrey K.S., Ketchum M.A., Wolf S.F. 8 Interleukin-12 as vaccine adjuvant. Characteristics of primary, recall, and ling- term responses. Ann. NY Acad. Sci. 1996; 795: 26 – 35.

19. Nunberg J.H., Doyle M.V., York S.M., York C.J. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl Acad. Sci. USA. 1989; 86: 4240 – 4243.

20. Pardoll D.M. Paracrine cytokine adjivants in cancer immunotherapy. Annu. Rev. Immunol. 1995; 13: 399 – 415.

21. Jennings V.M. Review of selected adjuvants used in antibody production. ILAR J. 1995; 37 (3): 119 – 125.

22. Stills H.F. Adjuvants and antibody production: dispelling the myths associated with Freund’s Complete and other adjuvants. ILAR J. 2005, 46, N.3:280 – 293.

23. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007; 19: 24 – 32.


Review

For citations:


Kozlov V.G., Khapchaev Yu.Kh., Ishmukhametov A.A. Application of Imunofan, Polioksidoniy, Ronkoleykin, Salmozan and Fosprenil for Stimulating the Humoral Immune Response in Rabbits Immunized against Enteroviruses. Epidemiology and Vaccinal Prevention. 2016;15(4):53-58. (In Russ.) https://doi.org/10.31631/2073-3046-2016-15-4-53-58

Views: 1429


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)